Pillstats
Rx only · Capsule, Extended Release · Oral

Carbamazepine

Brands: Carbatrol · Equetro · Carbamazepine

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers9 labelers
Packages27
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.561$1.12$1.68$2.24Dec 2025Apr 2026Jul 2026
$1.947
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
9
Active US suppliers
37%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K21K31K42K2025 Q12025 Q22025 Q32025 Q42026 Q1
33K
Rx · 2026 Q1
3.3M
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager7SUPPLYING
Takeda Pharmaceuticals America, Inc.unknown3SUPPLYING
Validus Pharmaceuticals LLCunknown3SUPPLYING
ANI Pharmaceuticals, Inc.unknown3SUPPLYING
Apotex Corp.unknown3SUPPLYING
Coupler LLCunknown3SUPPLYING
AvPAKunknown3SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 19, 2025
    RESOLVEDShortage resolved: Carbamazepine Capsule, Extended Release (Takeda Pharmaceuticals USA Inc.)

    Carbamazepine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Neurology.

  • Dec 19, 2025
    SHORTAGEDrug shortage: Carbamazepine Capsule, Extended Release (Takeda Pharmaceuticals USA Inc.)

    Carbamazepine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Neurology.